Aktiesnakken — September 2013
-
stadig short term 1-2 år ikke det vilde rent regnskabsmæssigt, men på 3-5 år sigt en vanvittig spændende aktie hvor væksten vil gå amok med flere og flere produkter
-
nej det er bare en gentagelse af hvad nørder som mig ved
-
Så fik jeg købt Corning 14,81 aka, hva med dig, venter du stadig?
-
still waiting
-
men tror jeg går med dig nu
-
-
The decision to withdraw the lixisenatide application follows discussions with the U.S. Food and
Drug Administration (FDA) regarding its proposed process for the review of interim data. Sanofi
believes that potential public disclosure of early interim data, even with safeguards, could potentially
compromise the integrity of the ongoing ELIXA study. Sanofi’s decision is not related to safety
issues or deficiencies in the NDA.
(basal insulin), the investigational LixiLan fixed-ratioHello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind